Exploring Haloxylon articulatum: a Sustainable Source of Allosteric EGFR Inhibitors with Promising Anticancer Activity

Reyadh R. AL-Rashidi; Amira ZAÏRI

doi:10.1007/s42250-025-01571-y

February 2, 2026Chemistry Africa

Exploring Haloxylon articulatum: a Sustainable Source of Allosteric EGFR Inhibitors with Promising Anticancer Activity

View at Publisher

Ask AI

Bookmark

Share

Key Points

Promising anticancer activity against specific cancer cells is observed.
Analyzed extracts from haloxylon articulatum reveal potent allosteric inhibitors of EGFR.
In vitro assays demonstrated effective inhibition of cancer cell growth with key focus on metabolism.
Highlights the potential of utilizing natural resources for innovative cancer therapies.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Exploration of allosteric EGFR inhibitors from Haloxylon articulatum shows promising anticancer activity, indicating a sustainable intervention for cancer treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

AL-Rashidi et al. (2026) studied this question.

synapsesocial.com/papers/69a765bcbadf0bb9e87da3e0 https://doi.org/10.1007/s42250-025-01571-y

View at Publisher

Ask AI

Bookmark

Share

Exploring Haloxylon articulatum: a Sustainable Source of Allosteric EGFR Inhibitors with Promising Anticancer Activity

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Exploring Haloxylon articulatum: a Sustainable Source of Allosteric EGFR Inhibitors with Promising Anticancer Activity

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading